{"pmid":32445204,"title":"Crisis Standard of Care: Management of Infantile Spasms during COVID-19.","text":["Crisis Standard of Care: Management of Infantile Spasms during COVID-19.","The Child Neurology Society collaborated with the Pediatric Epilepsy Research Consortium to issue an online statement April 6, 2020 of immediate recommendations to streamline diagnosis, treatment, and follow up of infantile spasms. The recommendations encourage use of telemedicine, outpatient over inpatient studies, and oral therapies as initial treatment. Each recommendation is earmarked as enduring if intended to outlast the pandemic, and limited if intended only during the duration of the pandemic. This article is protected by copyright. All rights reserved.","Ann Neurol","Grinspan, Zachary M","Mytinger, John R","Baumer, Fiona M","Ciliberto, Michael A","Cohen, Bruce H","Dlugos, Dennis J","Harini, Chellamani","Hussain, Shaun A","Joshi, Sucheta M","Keator, Cynthia G","Knupp, Kelly G","McGoldrick, Patricia E","Nickels, Katherine C","Park, Jun T","Pasupuleti, Archana","Patel, Anup D","Pomeroy, Scott L","Shahid, Asim M","Shellhaas, Renee A","Shrey, Daniel W","Singh, Rani K","Wolf, Steven M","Yozawitz, Elissa G","Yuskaitis, Christopher J","Waugh, Jeffrey","Pearl, Phillip L","32445204"],"abstract":["The Child Neurology Society collaborated with the Pediatric Epilepsy Research Consortium to issue an online statement April 6, 2020 of immediate recommendations to streamline diagnosis, treatment, and follow up of infantile spasms. The recommendations encourage use of telemedicine, outpatient over inpatient studies, and oral therapies as initial treatment. Each recommendation is earmarked as enduring if intended to outlast the pandemic, and limited if intended only during the duration of the pandemic. This article is protected by copyright. All rights reserved."],"journal":"Ann Neurol","authors":["Grinspan, Zachary M","Mytinger, John R","Baumer, Fiona M","Ciliberto, Michael A","Cohen, Bruce H","Dlugos, Dennis J","Harini, Chellamani","Hussain, Shaun A","Joshi, Sucheta M","Keator, Cynthia G","Knupp, Kelly G","McGoldrick, Patricia E","Nickels, Katherine C","Park, Jun T","Pasupuleti, Archana","Patel, Anup D","Pomeroy, Scott L","Shahid, Asim M","Shellhaas, Renee A","Shrey, Daniel W","Singh, Rani K","Wolf, Steven M","Yozawitz, Elissa G","Yuskaitis, Christopher J","Waugh, Jeffrey","Pearl, Phillip L"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445204","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/ana.25792","topics":["Prevention"],"weight":1,"_version_":1667600475925512192,"score":9.490897,"similar":[{"pmid":32298480,"title":"Management of Infantile Hemangiomas during the COVID Pandemic.","text":["Management of Infantile Hemangiomas during the COVID Pandemic.","The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of infantile hemangiomas via telemedicine. FDA/EMA approved monitoring guidelines, clinical practice guidelines and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation are included. The importance of communication with caregivers in the context of telemedicine is discussed and online resources for both hemangioma education and for propranolol therapy provided.","Pediatr Dermatol","Frieden, Ilona J","Puttgen, Katherine B","Drolet, Beth A","Garzon, Maria C","Chamlin, Sarah L","Pope, Elena","Mancini, Anthony J","Lauren, Christine T","Mathes, Erin F","Siegel, Dawn H","Gupta, Deepti","Haggstrom, Anita N","Tollefson, Megha M","Baselga, Eulalia","Morel, Kimberly D","Shah, Sonal D","Holland, Kristen E","Adams, Denise M","Horii, Kimberly A","Newell, Brandon D","Powell, Julie","McCuaig, Catherine C","Nopper, Amy J","Metry, Denise W","Maguiness, Sheilagh","32298480"],"abstract":["The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of infantile hemangiomas via telemedicine. FDA/EMA approved monitoring guidelines, clinical practice guidelines and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation are included. The importance of communication with caregivers in the context of telemedicine is discussed and online resources for both hemangioma education and for propranolol therapy provided."],"journal":"Pediatr Dermatol","authors":["Frieden, Ilona J","Puttgen, Katherine B","Drolet, Beth A","Garzon, Maria C","Chamlin, Sarah L","Pope, Elena","Mancini, Anthony J","Lauren, Christine T","Mathes, Erin F","Siegel, Dawn H","Gupta, Deepti","Haggstrom, Anita N","Tollefson, Megha M","Baselga, Eulalia","Morel, Kimberly D","Shah, Sonal D","Holland, Kristen E","Adams, Denise M","Horii, Kimberly A","Newell, Brandon D","Powell, Julie","McCuaig, Catherine C","Nopper, Amy J","Metry, Denise W","Maguiness, Sheilagh"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298480","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/pde.14196","e_drugs":["Propranolol"],"topics":["Prevention"],"weight":1,"_version_":1666138493336682496,"score":192.913},{"pmid":32484990,"title":"First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.","text":["First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.","A healthy patient presented to Klinikum Altmuhlfranken Weissenburg Hospital, Germany, with two-morning attacks of painful muscle spasm in left upper and lower limbs, without altered consciousness. Full examinations, radiological imaging, electroencephalography, lumbar puncture, and autoimmune profile were either normal or not consistent. Subsequent epileptic episodes were observed on admission day and following days; thus, the patient was diagnosed with focal epilepsy. The patient started to develop a fever and severe cough at day 4, and SARS-Coronavirus-2 was confirmed through a nasopharyngeal swap. She received anticonvulsants and symptomatic treatments and completely recovered. This report emphasizes on potential nervous system involvement in SARS-Coronavirus-2 pathogenesis. This article is protected by copyright. All rights reserved.","J Med Virol","Elgamasy, Sara","Kamel, Mohamed Gomaa","Ghozy, Sherief","Khalil, Adham","Morra, Mostafa Ebraheem","Islam, Sheikh Mohammed Shariful","32484990"],"abstract":["A healthy patient presented to Klinikum Altmuhlfranken Weissenburg Hospital, Germany, with two-morning attacks of painful muscle spasm in left upper and lower limbs, without altered consciousness. Full examinations, radiological imaging, electroencephalography, lumbar puncture, and autoimmune profile were either normal or not consistent. Subsequent epileptic episodes were observed on admission day and following days; thus, the patient was diagnosed with focal epilepsy. The patient started to develop a fever and severe cough at day 4, and SARS-Coronavirus-2 was confirmed through a nasopharyngeal swap. She received anticonvulsants and symptomatic treatments and completely recovered. This report emphasizes on potential nervous system involvement in SARS-Coronavirus-2 pathogenesis. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Elgamasy, Sara","Kamel, Mohamed Gomaa","Ghozy, Sherief","Khalil, Adham","Morra, Mostafa Ebraheem","Islam, Sheikh Mohammed Shariful"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484990","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26113","keywords":["coronavirus - infection - covid-19 - epilepsy - outbreak - case report - pandemic"],"locations":["Germany"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Case Report"],"weight":1,"_version_":1668532114919784448,"score":130.73502},{"pmid":32414996,"title":"Neurosurgery and Neurology Practices during the Novel COVID-19 Pandemic: A Consensus Statement from India.","text":["Neurosurgery and Neurology Practices during the Novel COVID-19 Pandemic: A Consensus Statement from India.","Background: The COVID-19 infection outbreak has aroused increasing attention and affected thousands of people nationwide. The long incubation period, high infectious rate, varied manifestation, and absence of effective treatment make it difficult to manage the disease transmission. Objective: The intended goals are to encourage efficient management of neurological and neurosurgical patients, resource utilization, and protecting the healthcare provider during the COVID-19 epidemic. Herein, we present a consensus statement from various centers in India. Methodology: In addition to the literature review, recommendations were included from neurologists and neurosurgeons from various centers in India. Results: Every patient presenting for treatment should be treated as a potential asymptomatic infected case. Patients should be categorized based upon the priority as acute (require immediate treatment/surgery within 24 h), sub-acute (requiring treatment within a maximum of 7-10 days), or chronic (requiring treatment within a month). Non-essential elective surgeries and outpatient clinics should be avoided after informing the patient(s). There is a high risk of aerosol dispersion during intubation and certain neurosurgical procedures particularly those involving drills and endoscopes. These procedures should be performed wearing full personal protective equipment. The workflow of the operating rooms should also be modified significantly. Minor modifications in personal and professional lifestyles and routine training to use the PPE will ensure efficient management of resources. Conclusion: These recommendations could be used to mitigate the risks and reduce exposure to other patients, public, and healthcare staff.","Neurol India","Gupta, Prakamya","Muthukumar, N","Rajshekhar, V","Tripathi, Manjari","Thomas, Sanjeev","Gupta, Sunil Kumar","Lal, Vivek","Pal, Pramod","Abraham, Mathew","Behari, Sanjay","Paliwal, Vimal","Singh, Daljit","Pandey, Sanjay","Narasimhan, Lakshmi","Srinivas, Dwarakanath","Panda, Samhita","Kale, S S","Chandra, P Sarat","32414996"],"abstract":["Background: The COVID-19 infection outbreak has aroused increasing attention and affected thousands of people nationwide. The long incubation period, high infectious rate, varied manifestation, and absence of effective treatment make it difficult to manage the disease transmission. Objective: The intended goals are to encourage efficient management of neurological and neurosurgical patients, resource utilization, and protecting the healthcare provider during the COVID-19 epidemic. Herein, we present a consensus statement from various centers in India. Methodology: In addition to the literature review, recommendations were included from neurologists and neurosurgeons from various centers in India. Results: Every patient presenting for treatment should be treated as a potential asymptomatic infected case. Patients should be categorized based upon the priority as acute (require immediate treatment/surgery within 24 h), sub-acute (requiring treatment within a maximum of 7-10 days), or chronic (requiring treatment within a month). Non-essential elective surgeries and outpatient clinics should be avoided after informing the patient(s). There is a high risk of aerosol dispersion during intubation and certain neurosurgical procedures particularly those involving drills and endoscopes. These procedures should be performed wearing full personal protective equipment. The workflow of the operating rooms should also be modified significantly. Minor modifications in personal and professional lifestyles and routine training to use the PPE will ensure efficient management of resources. Conclusion: These recommendations could be used to mitigate the risks and reduce exposure to other patients, public, and healthcare staff."],"journal":"Neurol India","authors":["Gupta, Prakamya","Muthukumar, N","Rajshekhar, V","Tripathi, Manjari","Thomas, Sanjeev","Gupta, Sunil Kumar","Lal, Vivek","Pal, Pramod","Abraham, Mathew","Behari, Sanjay","Paliwal, Vimal","Singh, Daljit","Pandey, Sanjay","Narasimhan, Lakshmi","Srinivas, Dwarakanath","Panda, Samhita","Kale, S S","Chandra, P Sarat"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414996","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.4103/0028-3886.283130","keywords":["covid-19","neurology","neurosurgery","protocols"],"locations":["India","India","India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666994545922932737,"score":120.413055},{"pmid":32327490,"title":"Keeping people with epilepsy safe during the Covid-19 pandemic.","text":["Keeping people with epilepsy safe during the Covid-19 pandemic.","OBJECTIVES: To provide information on the impact of the COVID-19 pandemic on people with epilepsy and provide consensus recommendations on how to provide the best possible care for people with epilepsy while avoiding visits to urgent care facilities and hospitalizations during the Novel Coronavirus pandemic. METHODS: The authors developed consensus statements in 2 sections. The first was \"How should we/clinicians modify our clinical care pathway for people with epilepsy during the COVID-19 pandemic?\" The second was \"What general advice should we give to people with epilepsy during this crisis? Authors individually scored statements on a scale of -10 (strongly disagree) to +10 (strongly agree). 5/11 recommendations for physicians and 3/5 recommendations for individuals/families were rated by all authors as 7 or above (strongly agree) on the first round of rating. Subsequently, a tele-conference was held where statements for which there was a lack of strong consensus were revised. RESULTS: After revision, all consensus recommendations received a score of 7 or above. The recommendations focus on administration of as much care as possible at home to keep people with epilepsy out of health care facilities, where they are likely to encounter COVID-19 (including strategies for rescue therapy), as well as minimization of risk of seizure exacerbation through adherence, and through ensuring a regular supply of medication. We also provide helpful links to additional helpful information for people with epilepsy and health providers. CONCLUSION: These recommendation may help healthcare professionals provide optimal care to people with epilepsy during the coronavirus pandemic.","Neurology","French, Jacqueline A","Brodie, Martin J","Caraballo, Roberto","Devinsky, Orrin","Ding, Ding","Jehi, Lara","Jette, Nathalie","Kanner, Andres","Modi, Avani C","Newton, Charles R","Patel, Archana A","Pennell, Page B","Perucca, Emilio","Sander, Josemir W","Scheffer, Ingrid E","Singh, Gagandeep","Williams, Emma","Wilmshurst, Jo","Cross, J Helen","32327490"],"abstract":["OBJECTIVES: To provide information on the impact of the COVID-19 pandemic on people with epilepsy and provide consensus recommendations on how to provide the best possible care for people with epilepsy while avoiding visits to urgent care facilities and hospitalizations during the Novel Coronavirus pandemic. METHODS: The authors developed consensus statements in 2 sections. The first was \"How should we/clinicians modify our clinical care pathway for people with epilepsy during the COVID-19 pandemic?\" The second was \"What general advice should we give to people with epilepsy during this crisis? Authors individually scored statements on a scale of -10 (strongly disagree) to +10 (strongly agree). 5/11 recommendations for physicians and 3/5 recommendations for individuals/families were rated by all authors as 7 or above (strongly agree) on the first round of rating. Subsequently, a tele-conference was held where statements for which there was a lack of strong consensus were revised. RESULTS: After revision, all consensus recommendations received a score of 7 or above. The recommendations focus on administration of as much care as possible at home to keep people with epilepsy out of health care facilities, where they are likely to encounter COVID-19 (including strategies for rescue therapy), as well as minimization of risk of seizure exacerbation through adherence, and through ensuring a regular supply of medication. We also provide helpful links to additional helpful information for people with epilepsy and health providers. CONCLUSION: These recommendation may help healthcare professionals provide optimal care to people with epilepsy during the coronavirus pandemic."],"journal":"Neurology","authors":["French, Jacqueline A","Brodie, Martin J","Caraballo, Roberto","Devinsky, Orrin","Ding, Ding","Jehi, Lara","Jette, Nathalie","Kanner, Andres","Modi, Avani C","Newton, Charles R","Patel, Archana A","Pennell, Page B","Perucca, Emilio","Sander, Josemir W","Scheffer, Ingrid E","Singh, Gagandeep","Williams, Emma","Wilmshurst, Jo","Cross, J Helen"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327490","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1212/WNL.0000000000009632","locations":["optimal"],"topics":["Prevention"],"weight":1,"_version_":1666138494669422593,"score":110.30172},{"pmid":32422121,"title":"Committee Recommendations for Resuming Cardiac Surgery Activity in the SARS-CoV-2 Era: Guidance from an International Cardiac Surgery Consortium.","text":["Committee Recommendations for Resuming Cardiac Surgery Activity in the SARS-CoV-2 Era: Guidance from an International Cardiac Surgery Consortium.","Recommendations for the safe and optimized resumption of cardiac surgery care, research and education during the SARS-CoV-2 era were developed by a cardiovascular research consortium, based in 19 countries and representing a wide spectrum of experience with COVID-19. This guidance document provides a framework for restarting cardiac surgery in the outpatient and inpatient settings, in accordance with the current understanding of SARS-CoV-2, the risks posed by interrupted cardiovascular care, and the available recommendations from major societies.","Ann Thorac Surg","Chikwe, Joanna","Gaudino, Mario","Hameed, Irbaz","Robinson, N Bryce","Bakaeen, Faisal G","Menicanti, Lorenzo","Doenst, Torsten","Zheng, Zhe","Lemma, Massimo","Falk, Volkmar","Tatoulis, James","Girardi, Leonard N","Fremes, Stephen","Ruel, Marc","32422121"],"abstract":["Recommendations for the safe and optimized resumption of cardiac surgery care, research and education during the SARS-CoV-2 era were developed by a cardiovascular research consortium, based in 19 countries and representing a wide spectrum of experience with COVID-19. This guidance document provides a framework for restarting cardiac surgery in the outpatient and inpatient settings, in accordance with the current understanding of SARS-CoV-2, the risks posed by interrupted cardiovascular care, and the available recommendations from major societies."],"journal":"Ann Thorac Surg","authors":["Chikwe, Joanna","Gaudino, Mario","Hameed, Irbaz","Robinson, N Bryce","Bakaeen, Faisal G","Menicanti, Lorenzo","Doenst, Torsten","Zheng, Zhe","Lemma, Massimo","Falk, Volkmar","Tatoulis, James","Girardi, Leonard N","Fremes, Stephen","Ruel, Marc"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422121","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.athoracsur.2020.05.004","keywords":["covid-19","cardiac surgery","coronavirus","pandemic","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1667254896748920833,"score":106.34245}]}